Integral Health Asset Management
Latest statistics and disclosures from Integral Health Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ANTM, ACHC, ARNA, CYTK, SAGE, and represent 21.29% of Integral Health Asset Management's stock portfolio.
- Added to shares of these 10 stocks: ANTM (+$13M), BIIB (+$12M), REGN (+$10M), UHS (+$9.5M), SNY (+$9.2M), ABC (+$8.0M), EW (+$6.7M), A (+$5.9M), FOLD, SAGE.
- Started 25 new stock positions in CMRX, FMTX, ACRS, A, ONEM, HRTX, BNTX, ABC, DTIL, SIBN.
- Reduced shares in these 10 stocks: NTLA (-$23M), CRL (-$10M), , , NVST (-$7.1M), , DHR (-$6.7M), , MGNX (-$5.6M), ACHC (-$5.3M).
- Sold out of its positions in ALLO, AMRN, BDX, BMY, CVS, CNC, CRL, EXEL, INSM, PODD. KZR, LH, MGNX, MCK, MRK, NSTG, SWAV, SGFY, THC, TVTX, RARE, VRTX, HZNP.
- Integral Health Asset Management was a net seller of stock by $-7.1M.
- Integral Health Asset Management has $363M in assets under management (AUM), dropping by 3.79%.
- Central Index Key (CIK): 0001773206
Tip: Access up to 7 years of quarterly data
Positions held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Integral Health Asset Management
Companies in the Integral Health Asset Management portfolio as of the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Anthem (ANTM) | 5.3 | $19M | +233% | 50k | 381.80 | |
| Acadia Healthcare (ACHC) | 4.5 | $16M | -24% | 260k | 62.75 | |
| Arena Pharmaceuticals Com New (ARNA) | 4.2 | $15M | +7% | 225k | 68.20 | |
| Cytokinetics Com New (CYTK) | 3.8 | $14M | 700k | 19.79 | ||
| Sage Therapeutics (SAGE) | 3.5 | $13M | +55% | 224k | 56.81 | |
| Biogen Idec (BIIB) | 3.3 | $12M | NEW | 35k | 346.26 | |
| Regeneron Pharmaceuticals (REGN) | 2.8 | $10M | NEW | 19k | 558.54 | |
| Globus Med Cl A (GMED) | 2.8 | $10M | +73% | 130k | 77.53 | |
| Medtronic SHS (MDT) | 2.7 | $9.9M | +60% | 80k | 124.12 | |
| Universal Hlth Svcs CL B (UHS) | 2.6 | $9.5M | NEW | 65k | 146.43 | |
| Sanofi Sponsored Adr (SNY) | 2.5 | $9.2M | NEW | 175k | 52.66 | |
| Blueprint Medicines (BPMC) | 2.4 | $8.8M | -14% | 100k | 87.96 | |
| LHC (LHCG) | 2.3 | $8.4M | -23% | 42k | 200.26 | |
| Mirati Therapeutics (MRTX) | 2.2 | $8.1M | 50k | 161.54 | ||
Setup an alertIntegral Health Asset Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Teleflex Incorporated (TFX) | 2.2 | $8.0M | +66% | 20k | 401.80 | |
| AmerisourceBergen (ABC) | 2.2 | $8.0M | NEW | 70k | 114.49 | |
| Envista Hldgs Corp (NVST) | 2.1 | $7.8M | -47% | 180k | 43.21 | |
| Fate Therapeutics (FATE) | 1.9 | $6.9M | +100% | 80k | 86.79 | |
| Edwards Lifesciences (EW) | 1.9 | $6.7M | NEW | 65k | 103.57 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.8 | $6.7M | +212% | 125k | 53.20 | |
| Aerie Pharmaceuticals (AERI) | 1.8 | $6.6M | +17% | 410k | 16.01 | |
| Denali Therapeutics (DNLI) | 1.7 | $6.4M | -16% | 81k | 78.44 | |
| Nevro (NVRO) | 1.7 | $6.3M | -5% | 38k | 165.79 | |
| Natera (NTRA) | 1.7 | $6.2M | +57% | 55k | 113.53 | |
| PerkinElmer (PKI) | 1.7 | $6.2M | -20% | 40k | 154.40 | |
| Reata Pharmaceuticals Cl A (RETA) | 1.6 | $5.9M | -4% | 42k | 141.52 | |
| Agilent Technologies Inc C ommon (A) | 1.6 | $5.9M | NEW | 40k | 147.80 | |
| Zimmer Holdings (ZBH) | 1.5 | $5.6M | -36% | 35k | 160.83 | |
| Accolade (ACCD) | 1.5 | $5.4M | +33% | 100k | 54.31 | |
| Intellia Therapeutics (NTLA) | 1.3 | $4.9M | -82% | 30k | 161.90 | |
| Ptc Therapeutics I (PTCT) | 1.3 | $4.7M | +9% | 110k | 42.27 | |
| Amicus Therapeutics (FOLD) | 1.3 | $4.6M | NEW | 475k | 9.64 | |
| Zai Lab Adr (ZLAB) | 1.2 | $4.4M | -44% | 25k | 177.00 | |
| Relay Therapeutics (RLAY) | 1.2 | $4.4M | +100% | 120k | 36.59 | |
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $4.2M | -37% | 25k | 169.52 | |
| Agilon Health | 1.1 | $4.1M | NEW | 100k | 40.57 | |
| Danaher Corporation (DHR) | 1.1 | $4.0M | -62% | 15k | 268.33 | |
| Biontech Se Sponsored Ads (BNTX) | 1.0 | $3.8M | NEW | 17k | 223.88 | |
| Pennant Group (PNTG) | 1.0 | $3.7M | +12% | 90k | 40.90 | |
| Alkermes SHS (ALKS) | 1.0 | $3.7M | NEW | 150k | 24.52 | |
| Replimune Group (REPL) | 1.0 | $3.5M | +26% | 90k | 38.42 | |
| Irhythm Technologies (IRTC) | 0.9 | $3.3M | NEW | 50k | 66.36 | |
| Aclaris Therapeutics (ACRS) | 0.8 | $3.1M | NEW | 175k | 17.56 | |
| Si-bone (SIBN) | 0.8 | $2.8M | NEW | 90k | 31.47 | |
| Axonics Modulation Technolog (AXNX) | 0.7 | $2.5M | 40k | 63.40 | ||
| Chemocentryx (CCXI) | 0.6 | $2.3M | +12% | 175k | 13.39 | |
| Apellis Pharmaceuticals (APLS) | 0.6 | $2.2M | NEW | 35k | 63.20 | |
| Cerecor (CERC) | 0.6 | $2.2M | +12% | 675k | 3.27 | |
| Precision Biosciences Ord (DTIL) | 0.6 | $2.2M | NEW | 175k | 12.52 | |
| Akero Therapeutics (AKRO) | 0.6 | $2.1M | 85k | 24.81 | ||
| BioMarin Pharmaceutical (BMRN) | 0.6 | $2.1M | -51% | 25k | 83.44 | |
| UnitedHealth (UNH) | 0.6 | $2.0M | NEW | 5.0k | 400.40 | |
| BioCryst Pharmaceuticals (BCRX) | 0.5 | $2.0M | -68% | 125k | 15.81 | |
| Myovant Sciences (MYOV) | 0.5 | $1.9M | +30% | 85k | 22.76 | |
| Seres Therapeutics (MCRB) | 0.5 | $1.8M | NEW | 75k | 23.85 | |
| Agios Pharmaceuticals (AGIO) | 0.5 | $1.7M | -30% | 30k | 55.10 | |
| 1life Healthcare (ONEM) | 0.5 | $1.7M | NEW | 50k | 33.06 | |
| Altimmune Com New (ALT) | 0.4 | $1.6M | NEW | 160k | 9.85 | |
| Heron Therapeutics (HRTX) | 0.4 | $1.6M | NEW | 100k | 15.52 | |
| Karyopharm Therapeutics (KPTI) | 0.4 | $1.5M | +200% | 150k | 10.32 | |
| Axogen (AXGN) | 0.4 | $1.5M | NEW | 70k | 21.61 | |
| Kura Oncology (KURA) | 0.4 | $1.5M | +16% | 70k | 20.86 | |
| Trillium Therapeutics Com New (TRIL) | 0.4 | $1.5M | NEW | 150k | 9.70 | |
| Forma Therapeutics Hldgs SHS (FMTX) | 0.3 | $1.1M | NEW | 45k | 24.89 | |
| Misonix (MSON) | 0.3 | $998k | 45k | 22.18 | ||
| Kadmon Hldgs (KDMN) | 0.2 | $871k | -25% | 225k | 3.87 | |
| Magenta Therapeutics (MGTA) | 0.2 | $734k | +15% | 75k | 9.79 | |
| Alector (ALEC) | 0.2 | $729k | -36% | 35k | 20.83 | |
| Chimerix (CMRX) | 0.2 | $600k | NEW | 75k | 8.00 | |
| Ardelyx (ARDX) | 0.1 | $531k | -26% | 70k | 7.59 | |
| Longboard Pharmaceuticals In (LBPH) | 0.1 | $274k | 30k | 9.13 | ||
Past Filings by Integral Health Asset Management
SEC 13F filings are viewable for Integral Health Asset Management going back to 2019
- Integral Health Asset Management 2021 Q2 restated filed Aug. 30, 2021
- Integral Health Asset Management 2021 Q2 filed Aug. 13, 2021
- Integral Health Asset Management 2021 Q1 filed May 10, 2021
- Integral Health Asset Management 2020 Q4 filed Feb. 16, 2021
- Integral Health Asset Management 2020 Q3 filed Nov. 16, 2020
- Integral Health Asset Management 2020 Q2 filed Aug. 14, 2020
- Integral Health Asset Management 2020 Q1 filed May 15, 2020
- Integral Health Asset Management 2019 Q4 filed Feb. 13, 2020